HomeEWTX • NASDAQ
add
Edgewise Therapeutics Inc
Previous close
$25.42
Day range
$23.62 - $25.01
Year range
$9.00 - $38.12
Market cap
2.29B USD
Avg Volume
836.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 40.43M | 37.28% |
Net income | -34.13M | -32.73% |
Net profit margin | — | — |
Earnings per share | -0.36 | 12.20% |
EBITDA | -39.89M | -37.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 492.54M | 70.02% |
Total assets | 511.28M | 64.21% |
Total liabilities | 22.40M | 7.01% |
Total equity | 488.88M | — |
Shares outstanding | 94.69M | — |
Price to book | 4.91 | — |
Return on assets | -19.38% | — |
Return on capital | -20.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -34.13M | -32.73% |
Cash from operations | -27.37M | -24.10% |
Cash from investing | 25.36M | 8.30% |
Cash from financing | 3.33M | 1,679.62% |
Net change in cash | 1.32M | 14.87% |
Free cash flow | -15.74M | -20.30% |
About
Founded
2017
Headquarters
Website
Employees
108
